Drug recall · April 19, 2023
Pantoprazole Sodium Delayed Release Tablets USP 40mg recall
Why: CGMP Deviations: Discoloration
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Pantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals Inc., Piscataway, NJ, 08854, By: Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahabubnagar- 509 301, India NDC 31722-713-10
- Lots / codes
Lot #: PAN22542, Exp. Date: 9/2024
- Quantity
- 2,352 bottles
- Company
- Hetero USA Inc, Piscataway, NJ
- Distribution
- Nationwide within the United States
- Initiated
- March 14, 2023 · N/A
- Classified
- April 11, 2023
- Reported
- April 19, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Pantoprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.